Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Goettingen – page 15

325 clinical trials in Goettingen, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Goettingen at a glance
325
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

325 trials in Goettingen

Open in trial search

Colorectal cancer

Not yet recruiting

Study of 5-Fluorouracil, Panitumumab, and Sotorasib for Patients with Advanced KRAS G12C Mutated Colorectal Cancer Not Eligible for Standard Chemotherapy

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fluorouracil
  • Sponsor:Fondation Franc.Cancerologie Digestive

Endocrine ophthalmopathy

Not yet recruiting

Study on the Effects of VRDN-003 for Patients with Active Thyroid Eye Disease

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:VRDN-003
  • Sponsor:Viridian Therapeutics Inc.

Systemic scleroderma

Not yet recruiting

Study comparing rapcabtagene autoleucel and rituximab in patients with severe refractory diffuse cutaneous systemic sclerosis

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:Novartis Pharma AG

Hypertrophic cardiomyopathy

Not yet recruiting

Study on Mavacamten for Adults with Symptomatic Obstructive Hypertrophic Cardiomyopathy

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Mavacamten
  • Sponsor:Myokardia Inc.

Acute myeloid leukaemia

Not yet recruiting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using CPX-351, Gemtuzumab Ozogamicin, and a Drug Combination

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:GPOH gGmbH

Breast cancer

Not yet recruiting

Study Comparing Imlunestrant with Standard Endocrine Therapy for Patients with Early ER+, HER2- Breast Cancer at Increased Risk of Recurrence

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Anastrozole
  • Sponsor:Eli Lilly & Co.

Macular oedema

Not yet recruiting

Study on the Effects of RO7200220 for Patients with Uveitic Macular Edema

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Humanised IgG2 monoclonal antibody against INTERLEUKIN-6
  • Sponsor:F. Hoffmann-La Roche AG

Acute myeloid leukaemia+1

Not yet recruiting

Study of Cytarabine and Daunorubicin for Treating Myeloid Leukemia in Children with Down Syndrome

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:Cytarabine
  • Sponsor:GPOH gGmbH

Neuroblastoma

Not yet recruiting

Study on Melphalan and Drug Combination for Low and Intermediate Risk Neuroblastoma Patients

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:University Of Cologne

Arteriosclerosis

Not recruiting

A study to evaluate the effect of olpasiran on major cardiovascular events in patients with atherosclerotic cardiovascular disease and high levels of lipoprotein(a)

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Amgen Inc.

Chronic kidney disease+1

Not recruiting

A Study Testing How Well BAY 3401016 Works and How Safe It Is in Adults Aged 18 to 45 Years with Alport Syndrome

Investigational
Countries:GermanyGermany
  • Participants:18–64 years
  • Sponsor:Bayer AG

A Study of Tarperprumig Safety and Effectiveness in Adults with Blood Vessel Inflammation Caused by ANCA Antibodies

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Alexion Pharmaceuticals Inc.

Other cities in Germany

The busiest research cities in the country

All 518 cities in Germany

Clinical research in Goettingen

What the registry says about research in the country

01 Cardiovascular Diseases and Stroke Research

Clinical trials in Göttingen are exploring cardiovascular diseases and acute ischemic stroke, with a focus on improving outcomes in people at high risk of serious events.

  • Atherosclerotic cardiovascular disease
  • Elevated lipoprotein(a)
  • Acute ischemic stroke
  • Testing new approaches to reduce event risk and improve recovery after stroke

These studies aim to support better prevention, emergency treatment, and long-term protection against major vascular complications.

02 Neoplasms and Cancer Therapy

A strong group of trials in Göttingen is centered on breast cancer, colorectal cancer, and selected pediatric and head and neck tumors, reflecting active work in oncology.

  • Breast neoplasms
  • Metastatic colorectal cancer
  • High-risk neuroblastoma and childhood renal tumors
  • Evaluating new cancer treatments and combinations to improve survival and disease control

Researchers are also studying treatment response in advanced and recurrent disease, helping refine care for both adults and children.

03 Nervous System Diseases and Brain Health

Trials in nervous system diseases are examining both stroke recovery and chronic neurological conditions, including diseases that affect movement and cognition.

  • Alzheimer’s disease and mild cognitive impairment
  • Amyotrophic lateral sclerosis
  • Multifocal motor neuropathy
  • Testing therapies aimed at slowing decline, improving symptoms, and supporting brain function

This area includes work on diagnostic value, symptom relief, and longer-term safety in progressive neurologic disorders.

04 Eye Diseases

Research on eye diseases is addressing conditions that can gradually affect vision, especially disorders linked to aging and inflammation.

  • Geographic atrophy and age-related macular degeneration
  • Uveitic macular edema
  • Assessing whether new eye-directed therapies can slow damage and preserve sight

These studies are focused on protecting visual function and finding better ways to manage chronic retinal disease.

05 Immune System Diseases and Allergy

Trials in immune system diseases are looking at allergy-related conditions and immune-mediated disorders that can affect quality of life and daily functioning.

  • House dust mite-induced allergic rhinitis and rhinoconjunctivitis
  • Acute pharyngitis
  • Multifocal motor neuropathy
  • Evaluating symptom relief and longer-term control of immune-driven disease

The research includes both treatment-focused studies and efforts to improve everyday symptom management.

06 Respiratory Tract Diseases and Neonatal Lung Care

In the area of respiratory tract diseases, investigators are studying common upper-airway illness as well as breathing outcomes in very premature infants.

  • Acute pharyngitis
  • Respiratory distress syndrome in preterm infants
  • Improving symptom control and early respiratory support

These trials aim to make care more effective for both short-term infection symptoms and early-life lung health.

07 Hemic and Lymphatic Diseases and Pediatric Blood Cancer

Research in hemic and lymphatic diseases is centered on childhood blood cancers, with attention to outcomes and treatment response in difficult-to-treat settings.

  • Myeloid leukemia in children with Down syndrome
  • Standard risk ALK-positive anaplastic large cell lymphoma
  • Testing strategies that may improve cure rates and survival

These studies reflect an effort to refine pediatric oncology care while maintaining strong safety and effectiveness standards.

08 Digestive System Diseases and Inflammatory Complications

Trials in digestive system diseases include supportive care for treatment-related bowel injury and painful inflammatory episodes.

  • Acute radiation proctitis
  • Gout and acute gout attack
  • Evaluating symptom relief and better control of inflammation-related discomfort

The studies are aimed at improving quality of life for patients dealing with gastrointestinal and inflammatory symptoms.

09 Male Urogenital Diseases and Prostate Cancer Supportive Care

Work in male urogenital diseases includes research on complications associated with treatment for prostate cancer, especially bowel side effects after radiation.

  • Prostate carcinoma
  • Acute radiation proctitis symptoms
  • Testing treatments that may reduce discomfort during cancer care

These trials focus on easing treatment burden and improving patient comfort during recovery.

10 Musculoskeletal Diseases and Movement Disorders

Several studies are investigating musculoskeletal diseases and related muscle disorders that affect strength, movement, and daily activity.

  • Myotonic dystrophy type 1 and type 2
  • Non-dystrophic myotonias
  • Gout
  • Assessing therapies that may improve muscle symptoms and reduce pain

This research area includes efforts to make symptom control more consistent for chronic neuromuscular conditions.

11 Psychiatry and Psychology

Clinical research in psychiatry and psychology is represented mainly through studies of cognitive decline and early dementia, where mental function and daily independence are key concerns.

  • Alzheimer’s disease
  • Newly diagnosed early-to-mild dementia
  • Mild cognitive impairment
  • Evaluating treatments intended to support cognition and slow worsening

These trials are designed to better understand disease progression and strengthen care options for patients and families.

12 Otorhinolaryngologic Diseases

Studies in otorhinolaryngologic diseases are addressing upper-airway and throat complaints, with an emphasis on easing bothersome symptoms.

  • Acute pharyngitis
  • Allergic rhinoconjunctivitis
  • Testing symptom-relief approaches for common ear, nose, and throat conditions

This line of research aims to improve comfort and day-to-day function for patients with frequent ENT problems.

13 Eye and Immune-Related Inflammation

Some trials bridge eye disease and immune-mediated inflammation, especially where swelling or tissue damage can threaten vision.

  • Uveitic macular edema
  • Geographic atrophy
  • Testing treatments that may preserve retinal structure and visual performance

These studies are focused on slowing progression and improving long-term eye health.

14 Unspecified and Cross-Cutting Research

Some clinical trials in Göttingen span more than one therapeutic area, bringing together cardiovascular, neurological, oncology, and rare disease research under broader care questions.

  • Acute ischemic stroke
  • Breast cancer and colorectal cancer
  • Alzheimer’s disease and myotonic disorders
  • Exploring whether new or combined treatments can improve outcomes across complex disease settings

This mix highlights a broad and active research environment with multiple specialties contributing to patient care.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.